The latest closing stock price for Beam Therapeutics as of February 21, 2025 is 30.43.
An investor who bought $1,000 worth of Beam Therapeutics stock at the IPO in 2020 would have $623 today, roughly 1 times their original investment - a 10.17% compound annual growth rate over 5 years.
The all-time high Beam Therapeutics stock closing price was 133.60 on July 01, 2021.
The Beam Therapeutics 52-week high stock price is 49.50, which is 62.7% above the current share price.
The Beam Therapeutics 52-week low stock price is 20.84, which is 31.5% below the current share price.
The average Beam Therapeutics stock price for the last 52 weeks is 26.63.
An investor who bought $1,000 worth of Beam Therapeutics stock at the IPO in 2020 would have $623 today, roughly 1 times their original investment - a 10.17% compound annual growth rate over 5 years.
The all-time high Beam Therapeutics stock closing price was 133.60 on July 01, 2021.
The Beam Therapeutics 52-week high stock price is 49.50, which is 62.7% above the current share price.
The Beam Therapeutics 52-week low stock price is 20.84, which is 31.5% below the current share price.
The average Beam Therapeutics stock price for the last 52 weeks is 26.63.